http://www.modernmedicine.com/modernmedicine/Ophthalmology/Article/list/40207 Industry news and clinical reports covering the diagnosis, monitoring, and medical and surgical treatment of all ocular and visual disorders. Topics cover the full spectrum of eye care, from prescribing glasses and contact lenses to complex and delicate eye surgery. Disease conditions include cornea and external disease, glaucoma, neuro-ophthalmologic disorders, vitreoretinal diseases and infections. 2009-11-21T22:19:18Z http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-Treated-Corneas-Found-Suitable-for-Donor-Tis/ArticleNewsFeed/Article/detail/643381?contextCategoryId=40207&ref=25 Laser in situ keratomileusis and photorefractive keratectomy are not likely associated with any significant long-term effect on the corneal endothelium, and may be used as donor tissue, according to a study published in the November issue of the Archives of Ophthalmology. 2009-11-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/643381/eye_SS36015.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/643381null XML http://www.modernmedicine.com/modernmedicine/Endocrinology/Drug-May-Reverse-Type-1-Diabetes-Ocular-Complicati/ArticleNewsFeed/Article/detail/642027?contextCategoryId=40207&ref=25 In rats induced with type 1 diabetes, topical treatment with naltrexone hydrochloride, an opioid antagonist, reverses dry eye and restores corneal sensitivity, according to a study in the November issue of the Archives of Ophthalmology. 2009-11-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642027/eyedrop_59237.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642027null XML http://www.modernmedicine.com/modernmedicine/Retinal+Disease/Cataract-Surgery-Unlikely-to-Affect-the-Progressio/ArticleNewsFeed/Article/detail/642025?contextCategoryId=40207&ref=25 In patients with non-neovascular age-related macular degeneration (AMD), cataract surgery is not associated with an increased risk of AMD progression. In addition, dietary fats may have differential effects on the risk of AMD, according to two studies in the November issue of the Archives of Ophthalmology. 2009-11-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642025/SS36006.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642025null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hemoglobin-A1C-Levels-May-Be-Better-Predictor-of-R/ArticleNewsFeed/Article/detail/641798?contextCategoryId=40207&ref=25 Hemoglobin A1C levels are a better predictor of retinopathy than fasting plasma glucose, according to a study in the November Diabetes Care. In a related study in the same issue, researchers report that routine lowering of blood pressure and intensive glucose control substantially improve renal outcomes and reduces death in type 2 diabetes patients. 2009-11-13T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/641798/Sen002ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/641798null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-Surgery-May-Benefit-Macular-Degeneration/ArticleNewsFeed/Article/detail/640328?contextCategoryId=40207&ref=25 Individuals with varying degrees of age-related macular degeneration may benefit in terms of visual acuity from cataract surgery, according to the Age-Related Eye Disease Study published in the November issue of Ophthalmology. 2009-11-09T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640328/eyechart.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640328null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cellular-Pathway-Implicated-in-Diabetic-Retinopath/ArticleNewsFeed/Article/detail/640100?contextCategoryId=40207&ref=25 An additional cellular signaling pathway activated by hyperglycemia is involved in the death of retinal cells that lead to diabetic retinopathy, according to a study published online Nov. 1 in Nature Medicine. 2009-11-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/640100/Sen002ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/640100null XML http://www.modernmedicine.com/modernmedicine/Ophthalmology+Top+Story/Ophthalmologists-role-in-preventing-diabetic-eye-d/ArticleStandard/Article/detail/639680?contextCategoryId=40207&ref=25 Eye-care providers can contribute to early diagnosis, improved prognosis, and prevention of the complications of late-stage eye disease caused by diabetes. 2009-11-05T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/modernmedicine/452009/639680null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Looks-at-Five-Year-Effect-of-Treatment-in-Ma/ArticleNewsFeed/Article/detail/639867?contextCategoryId=40207&ref=25 Intravitreal triamcinolone acetonide may be helpful in treating some cases of advanced diabetic macular edema, according to research published in the November issue of Ophthalmology. 2009-11-05T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639867/SS36006.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639867null XML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Topcon-introduces-image-management-sharing-softwar/ArticleStandard/Article/detail/639010?contextCategoryId=40207&ref=25 Topcon Medical Systems Inc. introduced a new image management and sharing software suite (EyeRoute) at the recent American Academy of Ophthalmology annual meeting. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639010null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/IRIDEX-launches-two-photocoagulator-systems/ArticleStandard/Article/detail/639037?contextCategoryId=40207&ref=25 IRIDEX Corp. launched a dual-port ophthalmic green laser photocoagulator (IQ 532) and a modular multi-wavelength laser photocoagulator at the recent annual meeting of the American Academy of Ophthalmology. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639037null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Notal-Vision-sells-Foresee-PHP-business-to-Reicher/ArticleStandard/Article/detail/638996?contextCategoryId=40207&ref=25 Notal Vision has sold its clinic-based preferential hyperacuity perimeter (Foresee PHP) business to Reichert Ophthalmic Instruments. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/638996null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/MacuSight-gets-FDA-fast-track-designation-for-DME-/ArticleStandard/Article/detail/639006?contextCategoryId=40207&ref=25 MacuSight has received fast-track designation from the FDA for its proprietary ocular sirolimus (Perceiva) product for the treatment of diabetic macular edema. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639006null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Ellex-unveils-new-generation-of-diagnostic-ultraso/ArticleStandard/Article/detail/639015?contextCategoryId=40207&ref=25 Ellex Medical Lasers Ltd. unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639015null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Lumenis-unveils-retinal-laser-delivery-technology/ArticleStandard/Article/detail/639042?contextCategoryId=40207&ref=25 Lumenis Ltd. introduced an ophthalmic laser delivery technology and slit lamp biomicroscope system (InSight) at the recent annual meeting of the American Academy of Ophthalmology. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639042null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Allergan-wins-brimonidine-patent-infringement-case/ArticleStandard/Article/detail/638993?contextCategoryId=40207&ref=25 The U.S. District Court for the District of Delaware has ruled in favor of Allergan Inc. in its patent infringement lawsuit against two sets of defendants seeking to market purported generic versions of the company?s formulations of brimonidine tartrate 0.1% and 0.15% (Alphagan P) for ocular hypertension and glaucoma. Specifically, the court ruled that Allergan's five patents related to the ophthalmic solutions are valid and enforceable. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/638993null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Abbott-completes-acquisition-of-Visiogen/ArticleStandard/Article/detail/639005?contextCategoryId=40207&ref=25 Abbott Laboratories has completed its acquisition of privately held eye-care company Visiogen, adding to its vision-care business an accommodating IOL technology (Synchrony) designed to address presbyopia in patients with cataracts. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639005null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/University-of-Nebraska-Medical-Center-plans-eye-in/ArticleStandard/Article/detail/639000?contextCategoryId=40207&ref=25 A major gift from an Omaha, NE, ophthalmologist will help fund construction of an eye institute at the University of Nebraska Medical Center (UNMC). 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/639000null HTML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/New-documentary-explores-life-of-Dr-Kelman/ArticleStandard/Article/detail/638990?contextCategoryId=40207&ref=25 "Through My Eyes: The Charlie Kelman Story," a 1-hour documentary about the ophthalmologist who developed the phacoemulsification technique of cataract removal, will premiere nationwide on public television Jan. 20, 2010, at 9 p.m. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/452009/638990null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/October-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/638301?contextCategoryId=40207&ref=25 2009-11-02T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638301null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Travoprost-A-prostaglandin-analogue-for-the-treatm/ArticleStandard/Article/detail/640137?contextCategoryId=40207&ref=25 In August 2003, the US Department of Veterans Affairs (VA) awarded a contract for prostaglandin ophthalmic agents with travoprost as the agent of choice. Although there was no national mandate to switch patients from existing therapy, many VA facilities had agreements from their local ophthalmology and optometry departments to conduct a therapeutic interchange of patients from existing prostaglandins (eg, latanoprost) to travoprost. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/formulary/452009/640137null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Barriers-to-Care-Among-Glaucoma-Patients-Exami/ArticleNewsFeed/Article/detail/637052?contextCategoryId=40207&ref=25 Simple clinic management issues, such as long waiting times and difficulty scheduling appointments, were cited as the primary barriers to optimal follow-up care among glaucoma patients, according to research presented at the fourth annual joint meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology, held from Oct. 24 to 27 in San Francisco. 2009-10-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637052/eyechart.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637052null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Myopia-May-Reduce-Risk-of-Diabetic-Retinopathy/ArticleNewsFeed/Article/detail/637054?contextCategoryId=40207&ref=25 People with diabetes who are nearsighted are at reduced risk for developing diabetic retinopathy and vision-threatening diabetic retinopathy, according to research presented at the fourth annual joint meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology, held from Oct. 24 to 27 in San Francisco. 2009-10-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637054/eyeexam_40291.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637054null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Gene-Therapy-Shows-Promise-in-Inherited-Sight-Diso/ArticleNewsFeed/Article/detail/636525?contextCategoryId=40207&ref=25 Gene therapy for a rare inherited sight disorder in which severely impaired vision in childhood usually results in blindness in adulthood can substantially improve vision, particularly in children, according to a study published online Oct. 24 in The Lancet. 2009-10-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/636525/sight_18121.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/636525null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Normal-Tension-Glaucoma-Treatment-Options-Explored/ArticleNewsFeed/Article/detail/634414?contextCategoryId=40207&ref=25 Untreated intraocular pressure and zone β variables of peripapillary atrophy may serve as risk factors for normal-tension glaucoma in young individuals with moderate to severe vision loss, according to a study in the October issue of the Archives of Ophthalmology. 2009-10-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634414/eye_40179.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634414null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/More-Very-Preterm-Births-Is-Raising-Retinopathy-In/ArticleNewsFeed/Article/detail/634219?contextCategoryId=40207&ref=25 The increasing number of extremely preterm babies who are surviving is increasing the incidence of retinopathy of prematurity, according to a study published in the October issue of the Archives of Ophthalmology. 2009-10-14T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634219/babyeye_SS36028.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634219null XML http://www.modernmedicine.com/modernmedicine/Endocrinology/Study-Evaluates-Hospital-Quality-and-Mortality-Rat/ArticleNewsFeed/Article/detail/633747?contextCategoryId=40207&ref=25 Hospital mortality rates in the United States have improved, although major differences in quality still exist between the best and worst hospitals, according to a report published Oct. 13 by HealthGrades. 2009-10-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747/hospitalsign_18169.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Early-AMD-May-Increase-Heart-Disease-Risk-in-Older/ArticleNewsFeed/Article/detail/633746?contextCategoryId=40207&ref=25 Older adults with early age-related macular degeneration may be at higher risk of coronary heart disease, according to the Cardiovascular Health Study published in the October issue of Ophthalmology. 2009-10-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633746/eyechart_59082.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633746null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Impairment-May-Affect-Mortality-Risk-in-Eld/ArticleNewsFeed/Article/detail/633520?contextCategoryId=40207&ref=25 Visual impairment that cannot be corrected increases the odds of mortality in older adults, especially among those younger than 75, according to a study published in the October issue of the Archives of Ophthalmology. 2009-10-12T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633520/eyechart_SS36019.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633520null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Midlife-Vision-Linked-to-Early-Childhood-Factors/ArticleNewsFeed/Article/detail/632260?contextCategoryId=40207&ref=25 Prenatal, childhood biological and social determinants may contribute to midlife visual function, according to a study in the October issue of Ophthalmology. 2009-10-07T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632260/eyeexam_40291.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632260null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-Contrast-Visibility-May-Be-Issue-for-Parkinson/ArticleNewsFeed/Article/detail/631866?contextCategoryId=40207&ref=25 Drivers with Parkinson's disease may be more prone to poor vehicle control and crashes while driving in low-contrast visibility conditions due to issues with perception, cognition and motor dysfunction, according to a study in the Oct. 6 issue of Neurology. 2009-10-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631866/elderly_driver.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631866null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Loss-Lower-in-Recently-Diagnosed-Type-1-Dia/ArticleNewsFeed/Article/detail/632032?contextCategoryId=40207&ref=25 People diagnosed with type 1 diabetes mellitus in more recent years have less prevalence of visual impairment than those diagnosed earlier, according to a study in the October issue of Ophthalmology. 2009-10-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632032/eyechart_59082.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632032null XML http://www.modernmedicine.com/modernmedicine/Ophthalmology/I-Therapeutix-changes-name-to-Ocular-Therapeutix/ArticleStandard/Article/detail/631238?contextCategoryId=40207&ref=25 I-Therapeutix has changed its name to Ocular Therapeutix. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631238null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Bausch-amp-Lomb-subsidiaries-CROMA-to-co-promote-b/ArticleStandard/Article/detail/631233?contextCategoryId=40207&ref=25 Several subsidiaries of Bausch & Lomb have been granted rights from CROMA Pharma GmbH to co-promote and sell bromfenac ophthalmic solution in Europe when it becomes available to that market, announced Bausch & Lomb. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631233null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/AMD-Alliance-International-organizes-video-contest/ArticleStandard/Article/detail/631188?contextCategoryId=40207&ref=25 AMD Alliance International is hosting a video contest to raise awareness for age-related macular degeneration (AMD). Individuals are invited to create and submit videos of no longer than 3 minutes that will communicate in the most creative and visually interesting ways the impact of AMD. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/402009/631188null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/FDA-approves-Sirions-NDA-for-ganciclovir-015-for-h/ArticleStandard/Article/detail/631228?contextCategoryId=40207&ref=25 The FDA has approved a new drug application (NDA) for ganciclovir ophthalmic gel 0.15% (Zirgan, Sirion Therapeutics) as a treatment for acute herpetic keratitis (dendritic ulcers), the company announced. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631228null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/AMO-launches-online-ordering-service/ArticleStandard/Article/detail/631232?contextCategoryId=40207&ref=25 Abbott Medical Optics (AMO) has launched a new online ordering service (AMOeasy, www.amoeasy.com) whereby customers can order the company?s implants and other cataract-related products as well as track orders at any time of day. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631232null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/World-Sight-Day-set-for-Oct-8/ArticleStandard/Article/detail/631236?contextCategoryId=40207&ref=25 Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct. 8. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631236null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Pieris-Allergan-collaborate-to-develop-treatments/ArticleStandard/Article/detail/631230?contextCategoryId=40207&ref=25 Pieris AG and Allergan will collaborate in the development of agents to treat serious ocular disorders, Pieris has announced. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631230null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Presbia-unveils-implantable-micro-lens/ArticleStandard/Article/detail/631234?contextCategoryId=40207&ref=25 Presbia Coöperatief U.A. of Amsterdam unveiled an implantable micro-lens treatment (Flexivue System) for presbyopia at the European Society of Cataract and Refractive Surgeons annual meeting. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631234null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/FDA-clears-Topcon-digital-fundus-camera/ArticleStandard/Article/detail/631229?contextCategoryId=40207&ref=25 The FDA has granted 510(k) clearance to a new digital fundus camera (TRC-NW7SF Mark II, Topcon Medical Systems), according to its manufacturer. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631229null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/September-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/630888?contextCategoryId=40207&ref=25 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/630888null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Stove-May-Improve-Womens-Respiratory-Health/ArticleNewsFeed/Article/detail/629587?contextCategoryId=40207&ref=25 In rural Mexican women, use of an improved wood-burning stove is associated with better respiratory function compared to a traditional open fire, according to a study in the Oct. 1 issue of the American Journal of Respiratory and Critical Care Medicine. 2009-09-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629587/respiratory.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629587null XML http://www.modernmedicine.com/modernmedicine/Nursing/Childhood-Nephrotic-Syndrome-Can-Cause-Lifelong-Il/ArticleNewsFeed/Article/detail/629418?contextCategoryId=40207&ref=25 Children with minimal-change nephrotic syndrome are at increased risk for osteoporosis, hypertension, sperm abnormalities and cataracts if the condition persists beyond puberty, according to a study published online Sept. 24 in the Clinical Journal of the American Society of Nephrology. 2009-09-25T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629418/kidney2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629418null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Two-new-imaging-device-models-are-available/ArticleStandard/Article/detail/626557?contextCategoryId=40207&ref=25 Heidelberg Engineering has two new models in its family of multimodality ophthalmic imaging devices (Spectralis). 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626557null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Alcon-to-acquire-ESBATech/ArticleStandard/Article/detail/626549?contextCategoryId=40207&ref=25 Alcon has announced in a prepared statement that it has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626549null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Allergan-Pieris-AG-agreement-targets-anticalin-for/ArticleStandard/Article/detail/626937?contextCategoryId=40207&ref=25 Pieris AG announced that it has entered into a collaboration agreement with Allergan Inc. that will combine Pieris' proprietary anticalin technology with Allergan's drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular disorders. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626937null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Abbott-expected-to-acquire-Visiogen/ArticleStandard/Article/detail/626555?contextCategoryId=40207&ref=25 Abbott has announced a definitive agreement to acquire Visiogen Inc. for $400 million in cash, providing the company with a next-generation accommodating IOL technology (Synchrony), according to a prepared statement. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626555null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Femtosecond-laser-receives-clearance-for-capsuloto/ArticleStandard/Article/detail/626558?contextCategoryId=40207&ref=25 LenSx Lasers Inc. announced that the FDA has granted 510(k) clearance for its femtosecond laser used for anterior capsulotomy during cataract surgery. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626558null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Dr-Travis-Meredith-is-new-AUPO-president/ArticleStandard/Article/detail/626560?contextCategoryId=40207&ref=25 Travis Meredith, MD, has been elected as the new president of the Association of University Professors of Ophthalmology (AUPO), which is composed of department chairmen, residency directors, and research directors of ophthalmology departments in the United States and Canada, according to a prepared statement. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626560null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/ISTA-reports-preliminary-results-for-investigation/ArticleStandard/Article/detail/626562?contextCategoryId=40207&ref=25 ISTA Pharmaceuticals has announced preliminary results from two recently completed studies of its investigational eye drop, prednisolone acetate 1.0% and tobramycin 0.3% (T-Pred). 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626562null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Bausch-amp-Lomb-to-consolidate-its-contact-lens-ma/ArticleStandard/Article/detail/626559?contextCategoryId=40207&ref=25 Bausch & Lomb intends to consolidate its worldwide contact lens manufacturing and proposes to begin moving most of its global contact lens production to its existing sites in Waterford, Ireland, and Rochester, NY, according to a prepared statement. ?? 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626559null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Ganciclovir-ophthalmic-gel-015-approved-by-FDA-for/ArticleStandard/Article/detail/626936?contextCategoryId=40207&ref=25 Sirion Therapeutics Inc. announced the FDA approval of its new drug application for ganciclovir ophthalmic gel 0.15% (Zirgan) as a treatment for acute herpetic keratitis. The FDA granted orphan drug designation to the gel for this indication in April 2007. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626936null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/FDA-approves-bepotastine-drops-for-ocular-itching/ArticleStandard/Article/detail/626550?contextCategoryId=40207&ref=25 The FDA has approved bepotastine besilate ophthalmic solution 1.5% (Bepreve, ISTA Pharmaceuticals) as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/626550null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Studies-Investigate-Hemifield-Damage-Race-in-Glauc/ArticleNewsFeed/Article/detail/627160?contextCategoryId=40207&ref=25 Individuals with glaucoma may have faster disease progression if they have initial damage to both hemifields, and people of African ancestry with and without glaucoma showed significant ocular differences compared to their counterparts of European descent, according to the results of two studies in the September Archives of Ophthalmology. 2009-09-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/627160/33101.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/627160null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Emerging-technology-aids-diabetic-retinopathy-scre/ArticleStandard/Article/detail/627833?contextCategoryId=40207&ref=25 Ophthalmologists should take a proactive approach toward the screening, management, and early treatment of diabetic retinopathy. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627833null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-lens-provides-high-definition-vision-benefits/ArticleStandard/Article/detail/627832?contextCategoryId=40207&ref=25 A new lens has been introduced into the market (iZon SL Lenses in Transitions VI, Ophthonix) that provides an ultraviolet-light-activated, changeable tint that can offer many HD vision benefits, including better vision in low luminance and intermediate contrast conditions. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627832null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Wine-Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/627819?contextCategoryId=40207&ref=25 Napa and Sonoma counties, located approximately an hour from San Francisco, are well known around the United States and the world for their superior wine and wineries. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627819null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Suites-at-Vision-Expo-West-moving-to-Palazzo-hotel/ArticleStandard/Article/detail/627830?contextCategoryId=40207&ref=25 The Suites at Vision Expo West (VEW) will be moving from the traditional location inside the Venetian Hotel to the new Palazzo Las Vegas. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627830null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Premium-frames-give-patients-originality-and-high-/ArticleStandard/Article/detail/627836?contextCategoryId=40207&ref=25 Despite the economy, there still are many patients who will be interested in premium frame collections. With premium frames you can offer patients luxury, technology, and fashion. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627836null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Sulcus-placement-of-a-proprietary-three-piece-mult/ArticleStandard/Article/detail/627822?contextCategoryId=40207&ref=25 Sulcus placement of a proprietary three-piece multifocal IOL (ReZoom, Abbott Medical Optics) is a viable option in eyes in which capsular bag support is not adequate to ensure good lens stability. Then, if the lens decenters in the sulcus, scleral suturing is a safe and effective option for recentering the IOL and restoring good vision. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627822null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Analysis-Competency-based-model-to-take-over-gradu/ArticleStandard/Article/detail/627825?contextCategoryId=40207&ref=25 The apprenticeship model suffers from inherent limitations that have called into question not only the safety but the quality, appropriateness, and effectiveness of the training model for residents. External stakeholders in the educational process, including the public, the payers, and the government, have called for reform in the graduate medical education process and for transformation from the apprenticeship model to a competency-based model of education. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627825null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Economic-storms-can-aid-ophthalmologic-practices-i/ArticleStandard/Article/detail/627824?contextCategoryId=40207&ref=25 Now is the time to focus on the lessons that can be learned in the current economic situation. Take a close look at your staffing levels, practices within your office, and the effect of days spent out of clinic by physicians, among other things, to try to identify ways to weather bad economic times better in the future. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627824null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/MBA-Is-this-the-right-decision-for-me/ArticleStandard/Article/detail/627839?contextCategoryId=40207&ref=25 Many, if not most, ophthalmologists have at least entertained the idea of obtaining a master of business administration degree. This three-part series is designed to provide guidance through the process. The first steps involve the realization of goals, the return on investment, and the application process. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627839null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pediatric-dispensing-for-any-age/ArticleStandard/Article/detail/627829?contextCategoryId=40207&ref=25 From babies to toddlers to pre-teens, there are many important considerations to implement when you are dispensing to kids. These considerations range from toddler eyes that are sensitive to ultraviolet rays to protective eyewear for your budding athlete. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627829null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Besifloxacin-Fluoroquinolone-developed-expressly-f/ArticleStandard/Article/detail/627828?contextCategoryId=40207&ref=25 Besifloxacin is the first chlorinated fluoroquinolone developed especially for use in the eye. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627828null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Adair-Eyewear-launches-Trendyreaderscom/ArticleStandard/Article/detail/627835?contextCategoryId=40207&ref=25 Adair Eyewear, a family owned eyewear retailer, has launched an online reading glass boutique called TrendyReaders.com. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627835null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Fourth-generation-fluoroquinolone-widens-the-choic/ArticleStandard/Article/detail/627820?contextCategoryId=40207&ref=25 The introduction of a new fourth-generation fluoroquinolone for ophthalmic use may prompt an assessment of the pros and cons of the available agents. James P. McCulley, MD, explains his continued preference for moxifloxacin 0.5% (Vigamox, Alcon). 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627820null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/San-Francisco-unmatched-as-a-travel-destination/ArticleStandard/Article/detail/627834?contextCategoryId=40207&ref=25 San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and household income are among the top in the nation, which enables a profitable restaurant and entertainment scene. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627834null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Triamcinolone-Studied-for-Vision-Loss-in-Macular-E/ArticleNewsFeed/Article/detail/626778?contextCategoryId=40207&ref=25 Intravitreal triamcinolone may improve visual acuity in patients with vision loss associated with macular edema due to perfused central retinal vein occlusion, but doesn't appear to improve visual acuity better than standard care in patients with macular edema secondary to branch retinal vein occlusion, according to research published in the September Archives of Ophthalmology. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626778/eyechart_SS36019.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626778null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Kill-kinetics-of-advanced-generation-fluoroquinolo/ArticleStandard/Article/detail/627827?contextCategoryId=40207&ref=25 An in vitro kill kinetics study evaluated eradication of 18 human ocular Staphylococcus isolates by commercial formulations of gatifloxacin 0.3% (Zymar, Allergan) and moxifloxacin 0.5% (Vigamox, Alcon Laboratories). Gatifloxacin demonstrated superior activity, which may be attributed to the presence of benzalkonium chloride 0.005% in its formulation. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627827null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dining-Please-your-appetite-in-Bay-City/ArticleStandard/Article/detail/627826?contextCategoryId=40207&ref=25 San Francisco has cuisine to satisfy many taste buds. From dim sum to gnocchi, use this guide to map out your dining tour of the city by the bay. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627826null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Diabetic-macular-edema-responds-to-ranibizumab-in-/ArticleStandard/Article/detail/627818?contextCategoryId=40207&ref=25 Diabetic macular edema responds to treatment with ranibizumab (Lucentis, Genentech), according to results of the RESOLVE study. The patient responses to the drug in the changes in the visual acuity and central macular thickness were significantly better in the groups treated with two concentrations of ranibizumab compared with the sham-treated group. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627818null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/FDA-resumes-review-of-toric-implantable-contact-le/ArticleStandard/Article/detail/627817?contextCategoryId=40207&ref=25 The FDA will resume scientific review of the STAAR Surgical Co. premarket approval (PMA) application for its toric implantable contact lens ([TICL]; Visian Toric Implantable Collamer Lens) for patients with myopia and astigmatism after removing the "integrity hold" restrictions it put in place in 2007, according to the company. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627817null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Jeffrey-P-Gilbard-MD-Dry-eye-pioneer-product-devel/ArticleStandard/Article/detail/627837?contextCategoryId=40207&ref=25 Fellow ophthalmologists and business partners are mourning the loss of Jeffrey P. Gilbard, MD, 55, whose career was filled with innovative ideas and solutions for treating dry eye disease. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627837null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vision-Expo-West-Win-big-in-Vegas/ArticleStandard/Article/detail/627831?contextCategoryId=40207&ref=25 Vision Expo West takes place from Sept. 30 to Oct. 3 at the Sands Expo and Convention Center, Las Vegas. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627831null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/How-to-cut-costs-without-cutting-staff/ArticleStandard/Article/detail/627838?contextCategoryId=40207&ref=25 The recession has affected medical practices, causing many to look at how money is spent. This five-partner practice cuts expenses creatively by not overlooking small details and has been able to prevent employee layoffs. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627838null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-care-patient-satisfaction-is-weighed-with-onli/ArticleStandard/Article/detail/627821?contextCategoryId=40207&ref=25 The co-authors conducted two studies to determine patient satisfaction related to their cataract-IOL surgeries, based on online health forums. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627821null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Surgeons-look-to-PRK-to-enhance-previous-LASIK/ArticleStandard/Article/detail/627823?contextCategoryId=40207&ref=25 William B. Trattler, MD, provides an overview of LASIK enhancements and explains why he frequently uses PRK for this purpose. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627823null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antibiotic-Class-Linked-to-Double-Vision/ArticleNewsFeed/Article/detail/624692?contextCategoryId=40207&ref=25 The use of fluoroquinolone antibiotics is associated with double vision, according to a study in the September issue of Ophthalmology. 2009-09-08T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624692/cipro.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624692null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Corneal-Transplant-Method-Appears-Safe-and-Effecti/ArticleNewsFeed/Article/detail/624688?contextCategoryId=40207&ref=25 A form of corneal transplantation to treat eye conditions characterized by corneal endothelial dysfunction is safe and effective, according to a review in the September issue of Ophthalmology. 2009-09-08T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624688/Sen002ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624688null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/DSEK-shown-to-be-safe-effective-therapy-according-/ArticleStandard/Article/detail/624925?contextCategoryId=40207&ref=25 Descemet's stripping endothelial Keratoplasty (DSEK) was shown to be a safe and effective treatment for corneal endothelial diseases, according to a 2009 review by the cornea panel of the American Academy of Ophthalmology's (AAO) Ophthalmic Technology Assessment Committee, led by W. Barry Lee, MD. 2009-09-08T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/372009/624925null HTML http://www.modernmedicine.com/modernmedicine/Feature+Articles/Abbott-to-buy-Visiogen-for-400-million/ArticleStandard/Article/detail/624117?contextCategoryId=40207&ref=25 Abbott announced a definitive agreement to acquire Visiogen Inc. for $400 million, providing the company with a next-generation accommodating IOL technology to address presbyopia for patients with cataracts. 2009-09-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/624117null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Art-exhibit-focuses-on-macular-degeneration/ArticleStandard/Article/detail/623206?contextCategoryId=40207&ref=25 To mark the global observance of AMD [age-related macular degeneration] Week, Lighthouse International and AMD Alliance International (AMDAI) will host an exhibit of the works of London-based portrait artist Adam Hahn, whose paintings illustrate how patients with AMD see the world. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623206null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Aton-expands-programs-for-preservative-free-timolo/ArticleStandard/Article/detail/623228?contextCategoryId=40207&ref=25 Aton Pharma has launched new education, distribution, sampling, and reimbursement programs for its preservative-free formulation of timolol maleate (Timoptic in Ocudose), which according to the company is the only preservative-free medication for glaucoma available in the United States. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623228null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/STAAR-Surgical-reports-progress-on-application-to-/ArticleStandard/Article/detail/623225?contextCategoryId=40207&ref=25 STAAR Surgical Co. President and Chief Executive Officer Barry G. Caldwell said he is “encouraged and pleased” with feedback the company has received from the Japanese government regarding the possibility of marketing its implantable contact lens ([ICL] Visian Implantable Collamer Lens) products there. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623225null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/CSI-Miami-episode-to-feature-Reichert-instrument/ArticleStandard/Article/detail/623204?contextCategoryId=40207&ref=25 The CBS crime drama 'CSI: Miami' will feature a proprietary automated lensometer (AL200, Reichert) in an episode airing Oct. 12, according to its manufacturer. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623204null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Hoya-Surgical-Optics-introduces-preloaded-IOL-inje/ArticleStandard/Article/detail/623227?contextCategoryId=40207&ref=25 Hoya Surgical Optics has introduced a preloaded IOL injection system (iSert) in the United States. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623227null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/ISTA-to-seek-bromfenac-label-change/ArticleStandard/Article/detail/623208?contextCategoryId=40207&ref=25 ISTA Pharmaceuticals plans to ask the FDA to approve a change to the label of its bromfenac 0.09% ophthalmic solution after obtaining positive preliminary phase III results in a confirmatory clinical study of once-daily bromfenac (Xibrom QD) for the treatment of inflammation and pain after cataract surgery. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623208null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/Pfizer-Private-Access-aim-to-accelerate-clinical-r/ArticleStandard/Article/detail/623230?contextCategoryId=40207&ref=25 Pfizer has entered into a collaboration with Private Access to create a new online community aimed at increasing clinical trial awareness and participation. It will be rolled out in phases starting late this year. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623230null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Glaucoma-Bimatoprost-tolerability-appears-to-be-en/ArticleStandard/Article/detail/627660?contextCategoryId=40207&ref=25 The efficacy and tolerability of continuing latanoprost 0.005% (Xalatan, Pfizer) after 6 weeks of latanoprost monotherapy versus switching to bimatoprost 0.03% (Lumigan, Allergan) was investigated in an investigator-masked, randomized, parallel-group trial. The results showed good efficacy and tolerability in patients whose therapy was switched to bimatoprost and suggest that bimatoprost may be tolerated better after latanoprost pre-treatment. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627660null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Glaucoma-Hyperemia-a-common-cause-for-medication-c/ArticleStandard/Article/detail/627662?contextCategoryId=40207&ref=25 Hyperemia is one of the main reasons why patients with glaucoma do not adhere to or persist with their topical therapeutic regimen. Patients end up switching to another possibly more tolerable medication, and the changing of medications has significant financial implications. Latanoprost has the lowest incidence of hyperemia among the prostaglandin analogs. Patient adherence is crucial in a chronic progressive disease such as glaucoma, where non-adherence can lead to visual loss and decline in quality of life, creating societal health and economic burdens. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627662null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ocular-perfusion-pressure-is-a-glaucoma-risk-accor/ArticleStandard/Article/detail/627663?contextCategoryId=40207&ref=25 Recent literature has identified ocular perfusion pressure as a glaucoma risk factor. Ophthalmologists need to be aware of the growing evidence supporting this theory, according to one expert. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627663null XML http://www.modernmedicine.com/modernmedicine/Industry+News/September-is-named-by-PBA-as-Home-Eye-Safety-Aware/ArticleStandard/Article/detail/623622?contextCategoryId=40207&ref=25 One in five at-home eye injuries are due to home repair or power tools according to results from the ?Sixth Annual Eye Injury Snapshot? by the American Academy of Ophthalmology and the American Society of Ocular Trauma. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/362009/623622null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Glaucoma-minishunt-under-scleral-flap-demonstrates/ArticleStandard/Article/detail/627665?contextCategoryId=40207&ref=25 A retrospective study analyzed outcomes of 345 consecutive eyes with the proprietary glaucoma minishunt (Ex-PRESS, Optonol) implanted, including 114 eyes having combined cataract surgery. During a mean follow-up of about 2 years, the implant provided effective IOP control whether used alone or in a combination procedure and was associated with few complications. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627665null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dont-go-postal-go-dental-remain-aloof-to-organized/ArticleStandard/Article/detail/627670?contextCategoryId=40207&ref=25 While ophthalmology has traveled down the road harnessed to organized medicine and thereby exposed to all of the exploding impediments to practice, dentistry has alertly remained aloof to these changes and continues to be viable, productive, and secure. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627670null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Preservative-free-IOP-lowering-medications-of-inte/ArticleStandard/Article/detail/627668?contextCategoryId=40207&ref=25 Results of a survey of 124 ophthalmologists show interest in preservative-free formulations of IOP-lowering medications to preserve ocular surface health. Preservative-free timolol maleate (Timoptic in Ocudose, Aton Pharma) can be a good choice for appropriately selected patients, according to one ophthalmologist. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627668null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Brimonidinetimolol-controls-IOP-in-clinical-settin/ArticleStandard/Article/detail/627652?contextCategoryId=40207&ref=25 Brimonidine 0.2%/timolol 0.5% fixed-combination ophthalmic solution effectively lowers and controls IOP and is likely to be associated with increased patient adherence to therapy and decreased unwanted side effects such as ocular irritation, according to one ophthalmologist. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627652null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Glaucoma-Latest-brimonidine-formulation-shows-impr/ArticleStandard/Article/detail/627653?contextCategoryId=40207&ref=25 A meta-analysis based on data from 12-month trials including patients treated with brimonidine 0.1% with a preservative (Alphagan P 0.1% with Purite, Allergan) and patients using brimonidine 0.15% (Alphagan P 0.15%, Allergan) showed better systemic safety and tolerability with the lower-concentration product. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627653null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hideo-Ozawa-Nidek-founder-merged-optics-electronic/ArticleStandard/Article/detail/627659?contextCategoryId=40207&ref=25 Hideo Ozawa, the founder and chairman of Nidek Co. Ltd., is being remembered as a visionary who combined optics and electronics to advance vision technology around the world. Ozawa, 79, died June 16. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627659null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Endocyclophotocoagulation-beneficial-for-those-wit/ArticleStandard/Article/detail/627664?contextCategoryId=40207&ref=25 Endocyclophotocoagulation (ECP) can be performed easily in patients with medically controlled glaucoma who are undergoing cataract surgery, to provide additional IOP lowering and reduce medication use. Misunderstanding that ECP is a completely different procedure than transscleral cyclodestruction contributes to under-use of this very safe procedure, according to one ophthalmologist. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627664null XML